Page last updated: 2024-08-23

phosphotyrosine and Idiopathic Pulmonary Fibrosis

phosphotyrosine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bi, XY; Cao, X; Chen, F; Chen, SJ; Cheng, PP; Feng, X; Hou, GQ; Jiang, YH; Li, Q; Li, SS; Liang, LM; Liu, AD; Liu, F; Lu, YZ; Ma, WL; Niu, Q; Song, LJ; Wang, M; Xiao, LY; Xu, H; Ye, H; Zhao, LQ; Zheng, YY; Zhou, LL1

Other Studies

1 other study(ies) available for phosphotyrosine and Idiopathic Pulmonary Fibrosis

ArticleYear
Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosis.
    Theranostics, 2022, Volume: 12, Issue:10

    Topics: Animals; Bleomycin; Cell Proliferation; Fibroblasts; Fibrosis; Idiopathic Pulmonary Fibrosis; Mice; Phosphotyrosine

2022